69 related articles for article (PubMed ID: 30212392)
1. SATB2 Is Superior to CDX2 in Distinguishing Signet Ring Cell Carcinoma of the Upper Gastrointestinal Tract and Lower Gastrointestinal Tract.
Ma C; Lowenthal BM; Pai RK
Am J Surg Pathol; 2018 Dec; 42(12):1715-1722. PubMed ID: 30212392
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Metastases to the Gastrointestinal Tract Presenting with Anemia and Intra-abdominal Bleed.
Khan I; Malik R; Khan A; Assad S; Zahid M; Sohail MS; Yasin F; Qavi AH
Cureus; 2017 Jul; 9(7):e1429. PubMed ID: 28924517
[TBL] [Abstract][Full Text] [Related]
3. Metastatic signet-ring carcinoma to the uterus presenting as an endometrial polyp.
Amin R; Wu CY; Lee JCS; Ananta MG
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37221007
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?
Bellizzi AM
Hum Pathol; 2020 Feb; 96():8-33. PubMed ID: 31857137
[TBL] [Abstract][Full Text] [Related]
5. Appendiceal Signet Ring Cell Carcinoma Presenting As Acute Appendicitis: A Case Report.
Ina EA; Sobczak A; Drzymalski K; Biglione A
Cureus; 2024 Apr; 16(4):e59137. PubMed ID: 38803764
[TBL] [Abstract][Full Text] [Related]
6. The effect of surgery and metastatic risk prediction in patients with gastrointestinal tract signet-ring cell carcinoma.
Chu Y; Long F; Ding X; Tian S
J Gastrointest Surg; 2024 May; ():. PubMed ID: 38740257
[TBL] [Abstract][Full Text] [Related]
7. Unusual Metastasis of Gastric Signet Ring Cell Carcinoma to the Breast: A Case Report of a Young Moroccan Patient.
Bendimya M; Kairouani M; El Magroud M; Bennani A; Al Jarroudi O; Brahmi SA; Afqir S
Cureus; 2024 Mar; 16(3):e56333. PubMed ID: 38629003
[TBL] [Abstract][Full Text] [Related]
8. Metastatic Primary Signet Ring Cell Carcinoma of Rectum: A Case Report of 10-Year-old Male Child.
Singh K; Singh A; Bhutra S; Pachori G; Jangir MK
J Clin Diagn Res; 2014 Feb; 8(2):177-8. PubMed ID: 24701526
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of SATB2 immunohistochemical expression in colorectal cancer versus primary ovarian mucinous neoplasms.
Maguire B; Duggan WP; Prehn JHM; Burke JP
Ann Diagn Pathol; 2024 Apr; 71():152302. PubMed ID: 38642469
[TBL] [Abstract][Full Text] [Related]
10. Exceptional Symbiosis Between Tumors: A Case of Gastric Signet Ring Cell Metastasis in Chromophobe Carcinoma of the Kidney.
Cieri M; Carrara S; Colombo P
Res Rep Urol; 2021; 13():45-48. PubMed ID: 33537247
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma with signet ring cell morphology: A diagnostic challenge.
Krishnamoorthy N; Veldore V; Sridhar PS; Govindrajan MJ; Prabhudesai S; Hazarika D; Ajaikumar BS
Asian J Neurosurg; 2016; 11(3):319-20. PubMed ID: 27366281
[TBL] [Abstract][Full Text] [Related]
12. The utility of PAX8 and SATB2 immunohistochemical stains in distinguishing ovarian mucinous neoplasms from colonic and appendiceal mucinous neoplasm.
Aldaoud N; Erashdi M; AlKhatib S; Abdo N; Al-Mohtaseb A; Graboski-Bauer A
BMC Res Notes; 2019 Nov; 12(1):770. PubMed ID: 31771640
[TBL] [Abstract][Full Text] [Related]
13. A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.
Meagher NS; Wang L; Rambau PF; Intermaggio MP; Huntsman DG; Wilkens LR; El-Bahrawy MA; Ness RB; Odunsi K; Steed H; Herpel E; Anglesio MS; Zhang B; Lambie N; Swerdlow AJ; Lubiński J; Vierkant RA; Goode EL; Menon U; Toloczko-Grabarek A; Oszurek O; Bilic S; Talhouk A; García-Closas M; Wang Q; Tan A; Farrell R; Kennedy CJ; Jimenez-Linan M; Sundfeldt K; Etter JL; Menkiszak J; Goodman MT; Klonowski P; Leung Y; Winham SJ; Moysich KB; Behrens S; Kluz T; Edwards RP; Gronwald J; Modugno F; Hernandez BY; Chow C; Kelemen LE; Keeney GL; Carney ME; Natanzon Y; Robertson G; Sharma R; Gayther SA; Alsop J; Luk H; Karpinskyj C; Campbell I; Sinn P; Gentry-Maharaj A; Coulson P; Chang-Claude J; Shah M; Widschwendter M; Tang K; Schoemaker MJ; Koziak JM; Cook LS; Brenton JD; Daley F; Kristjansdottir B; Mateoiu C; Larson MC; Harnett PR; Jung A; deFazio A; Gorringe KL; Pharoah PDP; Minoo P; Stewart C; Bathe OF; Gui X; Cohen P; Ramus SJ; Köbel M
Mod Pathol; 2019 Dec; 32(12):1834-1846. PubMed ID: 31239549
[TBL] [Abstract][Full Text] [Related]
14. SATB2 and CDX2 are prognostic biomarkers in DNA mismatch repair protein deficient colon cancer.
Ma C; Olevian D; Miller C; Herbst C; Jayachandran P; Kozak MM; Chang DT; Pai RK
Mod Pathol; 2019 Jul; 32(8):1217-1231. PubMed ID: 30962505
[TBL] [Abstract][Full Text] [Related]
15. SATB2 is a novel biomarker and therapeutic target for cancer.
Roy SK; Shrivastava A; Srivastav S; Shankar S; Srivastava RK
J Cell Mol Med; 2020 Oct; 24(19):11064-11069. PubMed ID: 32885593
[TBL] [Abstract][Full Text] [Related]
16. SATB2 in Neoplasms of Lung, Pancreatobiliary, and Gastrointestinal Origins.
De Michele S; Remotti HE; Del Portillo A; Lagana SM; Szabolcs M; Saqi A
Am J Clin Pathol; 2021 Jan; 155(1):124-132. PubMed ID: 32914850
[TBL] [Abstract][Full Text] [Related]
17. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract][Full Text] [Related]
18. SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
Hoskoppal D; Epstein JI; Gown AM; Arnold Egloff SA; Gordetsky JB; Shi CJ; Giannico GA
Histopathology; 2020 Mar; 76(4):550-559. PubMed ID: 31595536
[TBL] [Abstract][Full Text] [Related]
19. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
Bellizzi AM
Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
[TBL] [Abstract][Full Text] [Related]
20. SATB family chromatin organizers as master regulators of tumor progression.
Naik R; Galande S
Oncogene; 2019 Mar; 38(12):1989-2004. PubMed ID: 30413763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
